Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

The severe acute respiratory syndrome coronavirus 2 pandemic poses extraordinary
challenges. The tremendous number of coronavirus disease 2019 (COVID-19) cases in the …

Background Influenza epidemics were initially considered to be a suitable model for the
COVID-19 epidemic, but there is a lack of data concerning patients with chronic respiratory …

The year 2020 will be remembered as the year of the most significant global pandemic since
the Spanish influenza. As Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) …

With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 post …

Background The presence of co-morbidities, including underlying respiratory problems, has
been identified as a risk factor for severe COVID-19 disease. Information on the clinical …

Background Viral infections can cause significant morbidity in cystic fibrosis (CF). The
current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could …

Cystic fibrosis (CF) is one of the most common autosomal recessive life-limiting conditions
affecting Caucasians. The resulting defect in the cystic fibrosis transmembrane conductance …

There has been growing interest in telemedicine for cystic fibrosis over recent years based
largely on convenience for patients and/or increasing the frequency of surveillance and …

Viral infections are known to lead to serious respiratory complications in cystic fibrosis (CF)
patients. Hypothesizing that CF patients were a population at high risk for severe respiratory …